CeNeRx BioPharma, Inc., said it has initiated a Phase II clinical trial of its new formulation of TriRima, a novel antidepressant development as monotherapy for treatment-resistant business. CeNeRx has also announced it will present at the Biotech Showcase 2011 Tuesday, January 11, 2011 at 11:00 PST. Continue reading
Weil’s first project examines the health impact of a major campaign against malaria in Zambia, which has become a model in sub-Saharan Africa. The initiative, which involves the mass distribution of insecticide-treated bed nets, preventive treatment of pregnant women, spraying, rapid diagnostic tests and artemisinin-based therapy has helped reduce the mortality rate in Zambia by 60 % since 2003. Continue reading
The company has agreed to provide up to 4 million doses of flu vaccine in the agreement, even if it is not yet clear how many flu vaccines actually reach the U.S. by the end of flu season 2004 – 2005. Continue reading
Pediatrician Andrew Adesman, MD, agrees that the results of the project and the recent FDA communications should reassure parents and doctors. Continue reading
Earlier this year, under a research collaboration with Fate Therapeutics and TSRI, Dr. Ding and his team of scientists has become the first group to generate iPSCs using non-viral, non-DNA-based methods for reprogramming. Instead of inserting the reprogramming factors of October 3 / 4, Sox2, Klf4 and c-Myc DNA-based methods, such as viruses or plasmids, scientists have designed and used recombinant proteins to reprogram cells without genetic modification. The scientists found that those reprogrammed embryonic-like cells – called ‘protein-induced pluripotent stem cells’ or ‘PIPSC’ – from fibroblasts behave indiscriminately from classic embryonic stem cells in their molecular and functional features, including differentiation of various cell types such as beating cardiac muscle cells, neurons and cells of the pancreas Continue reading
Spherical how proteins are used in food industry as emulsifiers, gelling and foaming agents and in vitro, forming structures such as amyloid. The latter fibers have properties for texture favorable for the production of food or special facilities. The milk protein beta-lactoglubulin studied by Mezzenga and his colleagues are beginning to bubble and by heat treatment with acid aggregates into filamentous structures. Beta-lactoglobulin is a major component of whey and is therefore very important for the food industry. Continue reading
‘During our first test, we learned a lot from our patients first and last, in particular from 10-11 patients,’ said Dr. Walter-G. Wrobel, President and CEO of Retina Implant, AG. The eleventh patient, the last / in the study was the only one with the chip placed exactly in the macular region , and was able to see more clearly than any other patient in the study, in addition, each patient tolerated the surgery well;. adverse events occurred. ‘ Continue reading
Elisabeth Meyer Gender Harassment: Strategies to end sexism and homophobia in schools Continue reading
Research in Africa is based on previous work in Israel by researchers at the Kuvin Centre for the Study of Infectious and Tropical Diseases, Hebrew University of Jerusalem, which showed as attractors of plant origin with a bait of sugar can reduce toxic populations of mosquitoes that transmit malaria. Continue reading
The study is part of the University of Pittsburgh study pathogen model infectious funded by the National Institutes of Health. Continue reading